Thursday, January 05, 2006

New Products Are Expected to Be Introduced to the Cancer Vaccine Market over the Next Five Years

Genetic Engineering News, January 4, 2006
After years of promise, the cancer vaccine market is on the verge of huge growth - if it can overcome the clinical, regulatory and pharmacoeconomic obstacles. With a number of product launches expected over the next five years, this insightful market report takes a balanced view of the players and products that will shape this much awaited market sector. Even though more than half the 105 products in late-stage research will fail to make it to registration, the next five years will see a number of novel drug launches in a range of key cancers such as melanoma and those of the lung, breast and prostate. --Click the title of this post to read the full article from its source--


Post a Comment

<< Home

/* WebRing Code */